The use of heparin in preparing samples for blood-gas analysis.

The use of heparin in preparing samples for blood-gas analysis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The use of heparin in preparing samples for blood-gas analysis. Abstract Text:

Chris Higgins,Chris Higgins,

Heparin is the only anticoagulant used to prepare samples for blood-gas analysis. There are two ways in which heparin can interfere with results. The first is high heparin concentration in blood, and the second is heparin dilution of blood if liquid rather than dried (lyophilized) heparin is used. Traditional blood-gas analytes (pH, pCO2, and pO2) are less affected than electrolytes (particularly ionized calcium), also measured on modern blood-gas analyzers. The sample requirements as far as heparin is concerned are thus less exacting if only pH, pCO2, and pO2 are to be measured. For these analytes, it is still essential that the heparin (either sodium or lithium) concentration is less than 200 IU/mL blood and that the blood is not diluted more than 5%. The inclusion of electrolytes in the test repertoire excludes the use of sodium heparin in favor of lithium heparin. The inclusion of ionized calcium in the test repertoire demands that the heparin should be lyophilized, and the concentration should not exceed 10 IU/mL blood, unless a specialized heparin that eliminates the effect of calcium binding by heparin is used. Whatever the heparin formulation, it is essential for accurate results that the correct volume of blood is sampled to achieve a correct heparin concentration (and dilution, if liquid heparin is used), and that blood and anticoagulant are well mixed immediately after sampling. One of the most common practical problems associated with blood-gas analysis is inadequate anticoagulation and the formation of small blood clots that can block the sample pathway of blood-gas analyzers and invalidate results. Inadequate mixing of specimen with heparin is usually the problem. Clearly, the lower the heparin concentration the greater is the risk that poor mixing technique will give rise to inadequate anticoagulation and the associated problems.

The use of heparin in preparing samples for blood-gas analysis. Publishing Authors By Initials

C Higgins,C Higgins,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

The use of heparin in preparing samples for blood-gas analysis. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: MLO: medical laboratory observer

VOLUME: 39

Page Numbers: 16-8, 20; quiz 22-3

Journal Abbreviation:

ISSN: 0580-7247

DAY: 16

MONTH: Oct

YEAR: 2007

The use of heparin in preparing samples for blood-gas analysis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 225602

The use of heparin in preparing samples for blood-gas analysis. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: The use of heparin in preparing samples for blood-gas analysis. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The use of heparin in preparing samples for blood-gas analysis.

AFFILIATION:

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: MLO Med Lab Obs

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The use of heparin in preparing samples for blood-gas analysis Related Publications

• A bifunctional O-GlcNAc transferase governs flagellar motility through anti-repression.
• A navigation aid for the blind using tactile-visual sensory substitution.
• Adeno-associated viral vector-encoding vascular endothelial growth factor gene: effect on cardiovascular MR perfusion and infarct resorption measurements in swine.
• Allele-specific binding of CTCF to the multipartite imprinting control region KvDMR1.
• Bean alpha-amylase inhibitors in transgenic peas inhibit development of pea weevil larvae.
• Comparing phenotypes in patients with idiopathic autism to patients with velocardiofacial syndrome (22q11 DS) with and without autism.
• Discrimination of myocardial acute and chronic (scar) infarctions on delayed contrast enhanced magnetic resonance imaging with intravascular magnetic resonance contrast media.
• Effects of elicitation task variables on speech production by children with cochlear implants.
• Elevated relative mortality risk with mild-to-moderate chronic kidney disease decreases with age.
• First inelastic neutron scattering studies on thin free standing polymer films.
• Gene expression, intron density, and splice site strength in Drosophila and Caenorhabditis.
• Genomic approaches to understanding bacterial virulence.
• Growth rate toxicity phenotypes and homeostatic supercoil control differentiate Escherichia coli from Salmonella enterica serovar Typhimurium.
• Impact of prenatal cocaine exposure on child behavior problems through school age.
• Microarray analysis of Mu transposition in Salmonella enterica, serovar Typhimurium: transposon exclusion by high-density DNA binding proteins.
• Mutational bias suggests that replication termination occurs near the dif site, not at Ter sites: what's the Dif?
• Opposing effects of 5-HT(2A) and 5-HT (2C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test.
• Osteogenic protein-1 and related bone morphogenetic proteins regulate dendritic growth and the expression of microtubule-associated protein-2 in rat sympathetic neurons.
• PAI-1 is a Critical Upstream Regulator of the TGF-beta1/EGF-Induced Invasive Phenotype in Mutant p53 Human Cutaneous Squamous Cell Carcinoma.
• Patterns of sensitization to food and aeroallergens in the first 3 years of life.
• Progesterone receptor modulator for emergency contraception: a randomized controlled trial.
• Regulation of extracellular matrix remodeling following transforming growth factor-beta1/epidermal growth factor-stimulated epithelial-mesenchymal transition in human premalignant keratinocytes.
• Safety, tolerability and efficacy of indacaterol, a novel once-daily beta(2)-agonist, in patients with COPD: a 28-day randomised, placebo controlled clinical trial.
• Should we be CHARMed?
• System for the analysis and visualization of large 3D anatomical trees.
• The TGF-beta1/Upstream Stimulatory Factor-Regulated PAI-1 Gene: Potential Involvement and a Therapeutic Target in Alzheimer's Disease.
• The economic impact of reprocessing external fixation components.
• The impact of a genetics education program on physicians' knowledge and genetic counseling referral patterns.
• The use of heparin in preparing samples for blood-gas analysis.
• iTRAQ reagent-based quantitative proteomic analysis on a linear ion trap mass spectrometer.